Atherogenic lipoproteins and diabetes mellitus

Journal of Diabetes and its Complications

Volumn 16, Issue 1, 2002, Pages 29-34

  Yoshino, Gen ^a   Hirano, Tsutomu ^b   Kazumi, Tsutomu ^c  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Hyogo Rehabilitation Center Hospital   (Japan)

Author keywords

Acute myocardial infarction; dense LDL; Isolated hypo lipoproteinemia; Remnant fraction; Small; Type 2 diabetes

Indexed keywords

ACARBOSE; CHOLESTEROL; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TROGLITAZONE;

ATHEROGENESIS; CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIET; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; MICROALBUMINURIA; PARTICLE SIZE; PRIORITY JOURNAL; RISK FACTOR;

ALBUMINURIA; ARTERIOSCLEROSIS; CORONARY ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; OBESITY; RISK FACTORS;

EID: 0036181946     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1056-8727(01)00199-4     Document Type: Conference Paper

References (30)

1. Low-density lipoprotein subclass patterns and risk of myocardial infarction
2. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk
3. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease
4. Conformational differences in human apolipoprotein B-100 among subspecies of low density lipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridemic subjects
5. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects
6. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia
7. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease
8. LDL subclass phenotypes and triglyceride metabolism in non-insulin-dependent diabetes
9. Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity
10. Apolipoprotein-B structure and receptor recognition of triglyceride-rich low density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size
11. Long-term effect of bezafibrate in reduction of small, low-density lipoprotein by hypotriglyceridemic action
12. High prevalence of small LDL particles in non-insulin-dependent diabetic patients with nephropathy
13. Troglitazone and small low-density lipoprotein in type 2 diabetes
14. Atorvastatin increases low-density lipoprotein size and enhances high-density lipoprotein cholesterol concentration in male, but not in female patients with familial hypercholesterolemia
15. Lipoprotein metabolism in diabetes mellitus
16. Impaired endothelium-dependent acetylcholine-induced coronary artery relaxation in patients with high serum remnant lipoprotein particles
17. Abnormal lipoprotein composition in normolipidemic diabetic patients
18. Isolated low HDL cholesterol. An insulin-resistant state
19. Increased cholesterol concentrations in intermediate density lipoprotein fraction of normolipidemic non-insulin dependent diabetics
20. Small, dense low-density lipoprotein in Japanese men with coronary artery disease
21. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic man
22. A new assay method for the quantification of cholesterol in remnant-like particles in human serum using monoclonal anti-apo B100 and anti-apo A-1 immunoaffinity mixed gels
23. IPF2α-1: a novel index of lipid peroxidation in humans
24. Remnant-like particle cholesterol is a major risk factor for myocardial infarction in vasospastic angina with nearly normal coronary artery
25. Diabetes and atherosclerosis
26. Protective effect of fluvastatin sodium (XU-62-320), a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, on oxidative modification of human low-density lipoprotein in vitro
27. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease
28. Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size
29. Role of oxidized low density lipoprotein in atherogenesis
30. Cholesterol-enrichment of low density lipoprotein fraction is absent in normolipidemic diabetic subjects